Tuesday, February 24, 2026

Latest
Aya Intersects New Structure At Boumadine Parallel To Main Trend
Paramount Said To Have Submitted Revised Offer For Warner Bros Discovery
Cuba’s Energy Lifeline Hinges On A Russian Tanker Heading Into US Blockade Waters
UK Unveils Refinery Protection Plan as Carbon Costs Threaten Industry Survival
Trump Pressures Netflix to Remove Board Member Susan Rice Amid Warner Bros. Merger Review
Trump Warns Embargoes Are On Table After Tariff Loss
Trump Now Uses Lowercase Letters, But It’s Not What You Think
Brazilian State Firm Moves to Block Equinox Gold Asset Sale to China’s CMOC
Bitcoin Plunges 5% as Trump Tariff Threat Triggers $500M in Crypto Liquidations
EU Parliament Moves to Freeze US Trade Deal Ratification
Search

Revive Therapeutics

Revive Therapeutics Considers Exploring Bucillamine For Treatment Of Monkeypox
August 29, 2024, 10:31:20 AM
Read More

Revive Therapeutics Announces Final Stages In Bucillamine Phase 3 Clinical Trial For COVID-19
January 19, 2022, 09:28:00 AM
Read More

Revive Therapeutics Adds Turkish Subjects To Bucillamine Phase 3 Clinical Trial For COVID-19
December 30, 2021, 12:49:00 PM
Read More

Revive Therapeutics Includes Treating Omicron Variant In Bucillamine Research
December 3, 2021, 02:56:00 PM
Read More

Revive Therapeutics Announces Research Collaboration Agreement For Psilocybin Microneedle Patch
November 3, 2021, 09:29:00 AM
Read More

Revive Therapeutics Enters Exclusive License For Ganoderma Lucidum Intellectual Property
August 18, 2021, 09:23:10 AM
Read More

Revive Therapeutics Provides Update On Current Psilocybin Programs
August 10, 2021, 08:36:06 AM
Read More

Revive Therapeutics Begins Laying Groundwork For Commercialization Of Bucillamine
July 15, 2021, 02:27:50 PM
Read More

Revive Therapeutics Partners With University of Health Sciences Antigua To Further Psychedelics Research
June 17, 2021, 08:45:27 AM
Read More

Revive Therapeutics Looks To Bring Bucillamine To India
June 8, 2021, 09:15:00 AM
Read More
Latest News
Aya Intersects New Structure At Boumadine Parallel To Main Trend
Paramount Said To Have Submitted Revised Offer For Warner Bros Discovery
Cuba’s Energy Lifeline Hinges On A Russian Tanker Heading Into US Blockade Waters
UK Unveils Refinery Protection Plan as Carbon Costs Threaten Industry Survival
Trump Pressures Netflix to Remove Board Member Susan Rice Amid Warner Bros. Merger Review
Trump Warns Embargoes Are On Table After Tariff Loss
Trump Now Uses Lowercase Letters, But It’s Not What You Think
Brazilian State Firm Moves to Block Equinox Gold Asset Sale to China’s CMOC
Bitcoin Plunges 5% as Trump Tariff Threat Triggers $500M in Crypto Liquidations
EU Parliament Moves to Freeze US Trade Deal Ratification
Video Articles

Can the World Actually Supply $6 Copper? | Greg Ferron – PTX Metals

1911 Gold: The Power Of A Mine Restart

Is Gold Repeating the 2005 Setup Before The Big Run? | Geordie Mark
Recommended

Goliath Resources Sees 13% Grade Boost As Stifel Draws Parallels To Great Bear

First Majestic Q4 2025: Record Revenue, Earnings, Annual Silver Output
Trending
© 2026
the deep dive
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.